Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)

This prospective phase I study assessed the use of SBRT to treat all tumor sites along with intermittent androgen deprivation therapy (ADT) in patients with hormone sensitive oligometastatic prostate cancer. Primary endpoint was incidence of SBRT induced late toxicities. Secondary endpoints included various measures of treatment efficacy including cumulative incidence of developing of castration resistant prostate cancer (CRPC) and overall...